Treace Medical Concepts, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $3.2M | $12.1M |
| FY2020 | $29.2M | $776.0K | $18.1M |
| FY2021 | $29.4M | $93.1M | $105.8M |
| FY2022 | $52.7M | $60.5M | $19.5M |
| FY2023 | $53.0M | $137.9M | $13.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $3.2M | $12.1M |
| FY2020 | $29.2M | $776.0K | $18.1M |
| FY2021 | $29.4M | $93.1M | $105.8M |
| FY2022 | $52.7M | $60.5M | $19.5M |
| FY2023 | $53.0M | $137.9M | $13.0M |